와이바이오로직스: directors' dealings · South Korea · DART (FSS) DART:company-9ef41c KR KR · DART (FSS) Mcap 342.3Bn€
Explore the full insider trade history of 와이바이오로직스, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Market capitalisation: €342.3bn. The latest transaction was reported on 23 April 2026 — Other. Among the most active insiders: 와이바이오로직스. All data is free.
€412,248
1 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Income statement
Revenue 2.91 Bn€
Gross profit 2.38 Bn€ 82% margin
Net income −42.02 Bn€ -1442.7% margin
Balance sheet & cash
Market cap 342.34 Bn€
Total debt 14.69 Bn€
Free Cash Flow −7.26 Bn€
Last declaration on 23 April 2026
Declarations 6 total
Executives ● Other0 DART
DART:20260423000589 · 23 Apr 2026 details not loaded
Executives ● Other2 DART
0
DART:20260416000451 · 16 Apr 2026
Executives ● Purchase30 DART
€339,892 60,000 shares @ €5.6649 0.0001% mcap 100.0% of flow
DART:20260416000484 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase30 DART
€299,557 20,000 shares @ €14.9779 0.0001% mcap 100.0% of flow
DART:20260319000817 · 17 Mar 2026
Ideal exit: 12 Dec 2026 (T+270) Executives ● Sale2 DART
€412,248 20,000 shares
DART:20260319000792 · 19 Mar 2026
Executives ● Other0 DART
DART:20260317000592 · 17 Mar 2026 details not loaded